Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Metlife (MET) EBT (2016 - 2026)

Metlife's EBT history spans 18 years, with the latest figure at $1.5 billion for Q1 2026.

  • Quarterly EBT rose 11.3% to $1.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $4.8 billion through Mar 2026, down 18.83% year-over-year, with the annual reading at $4.7 billion for FY2025, 17.09% down from the prior year.
  • EBT came in at $1.5 billion for Q1 2026, up from $1.1 billion in the prior quarter.
  • In the past five years, EBT ranged from a high of $2.0 billion in Q4 2022 to a low of $257.0 million in Q1 2023.
  • The 5-year median for EBT is $1.2 billion (2024), against an average of $1.2 billion.
  • Year-over-year, EBT soared 564.95% in 2022 and then tumbled 86.72% in 2023.
  • Metlife's EBT stood at $2.0 billion in 2022, then tumbled by 53.55% to $941.0 million in 2023, then skyrocketed by 46.76% to $1.4 billion in 2024, then fell by 19.12% to $1.1 billion in 2025, then surged by 34.91% to $1.5 billion in 2026.
  • Per Business Quant, the three most recent readings for MET's EBT are $1.5 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.2 billion (Q3 2025).